Painful diabetic neuropathy is a common complication of diabetes mellitus and can affect many aspects of life and severely limit patients' daily functions. Signals of painful diabetic neuropathy are believed to originate in the peripheral nervous system. However, its peripheral mechanism of hyperalgesia has remained elusive. Numerous studies have accumulated that polymodal nociceptive C-fibres play a crucial role in the generation and conduction of pain signals and sensitization of which following injury or inflammation leads to marked hyperalgesia. Traditionally, the number of nociceptive primary afferent firings is believed to be determined at the free nerve endings, while the extended main axon of unmyelinated C-fibres only involves the reliable and faithful propagation of firing series to the central terminals. We challenged this classic view by showing that conduction of action potential can fail to occur in response to repetitive activity when they travel down the main axon of polymodal nociceptive C-fibres. Quantitative analysis of conduction failure revealed that the degree of conduction failure displays a frequency-dependent manner. Local administration of low threshold, rapidly activating potassium current blocker, a-dendrotoxin (0.5 nM) and persistent sodium current blocker, low doses of tetrodotoxin (5100 nM) on the main axon of C-fibres can reciprocally regulate the degree of conduction failure, confirming that conduction failure did occur along the main axon of polymodal nociceptive C-fibres. Following streptozotocin-induced diabetes, a subset of polymodal nociceptive C-fibres exhibited high-firing-frequency to suprathreshold mechanical stimulation, which account for about one-third of the whole population of polymodal nociceptive C-fibres tested. These high-firing-frequency polymodal nociceptive C-fibres in rats with diabetes displayed a marked reduction of conduction failure. Delivery of low concentrations of tetrodotoxin and Nav1.8 selective blocker, A-803467 on the main axon of C-fibres was found to markedly enhance the conduction failure in a dose-dependent manner in diabetic rats. Upregulated expression of sodium channel subunits Nav1.7 and Nav1.8 in both small dorsal root ganglion neurons and peripheral C-fibres as well as enhanced transient and persistent sodium current and increased excitability in small dorsal root ganglion neurons from diabetic rats might underlie the reduced conduction failure in the diabetic high-firing-frequency polymodal nociceptive C-fibres. This study shed new light on the functional capability in the pain signals processing for the main axon of polymodal nociceptive C-fibres and revealed a novel mechanism underlying diabetic hyperalgesia.
Introduction
Some patients with diabetic neuropathy develop severe pain, which can be extremely difficult to treat. This painful signal is believed to originate in the PNS; however, the exact peripheral mechanisms underlying diabetic hyperalgesia are not well understood (Calcutt, 2002; Schmader, 2002; Gooch and Podwall, 2004; Ørstavik et al., 2006; Ziegler, 2008) . A subset of nociceptive primary sensory neurons can exhibit high frequency firing to sustained mechanical stimulation under diabetic conditions, suggesting that the increased firing in nociceptors may contribute to the exaggerated pain seen in diabetic neuropathy Levine, 2001, 2003) . Despite these observations, the precise mechanisms giving rise to nociceptor hypersensitivity remain elusive. Classically, the number of primary afferent firings is believed to be determined at the free nerve endings in the periphery, whereas the extended main axon of unmyelinated C-fibres (C-fibres located within the trunk of peripheral nerve that lack branch points) only involves the reliable and faithful propagation of firing series to the central terminals (Grossman et al., 1979; Koester and Siegelbaum, 2000; Debanne, 2004) . Our recent study, however, demonstrated that conduction of action potentials along the main axon of peripheral unmyelinated C-fibres failed to occur following repetitive activity under normal conditions (Zhu et al., 2009 ). This conduction failure was accompanied by a parallel progressive slowing and fluctuation of conduction velocity. This result indicates that regulation of the neural signal can be achieved along the main axon of peripheral unmyelinated C-fibres. Among the peripheral unmyelinated C-fibres, a considerable proportion are nociceptive and respond to multiple stimulus modalities, namely polymodal nociceptors (Hu and Zhu, 1989; Meyer et al., 2006) . Numerous studies have provided evidence that polymodal nociceptive C-fibres play a crucial role in the generation and conduction of pain signals and sensitization of which following injury or inflammation ultimately leads to marked hyperalgesia (LaMotte et al., 1982; Meyer et al., 2006) . Therefore, we were interested to establish whether conduction failure occurs during the propagation of pain signals along the main axon of polymodal nociceptive C-fibres. If so, would the degree of conduction failure be altered after injury or inflammation? What is the functional significance of conduction failure along the main axon of polymodal nociceptive C-fibres? What candidates are involved in the generation of conduction failure and its plastic changes in the pathological states?
To address the above questions, we used a combination of single polymodal nociceptive C-fibre recording and immunostaining methods as well as biochemical assays to investigate the conduction properties of the main axon of polymodal nociceptive C-fibres. In the present study, we demonstrated that the degree of conduction failure was significantly decreased in a subset of high-firing-frequency polymodal nociceptive C-fibres following streptozotocin-induced diabetes. Upregulated expression of sodium channel subunits Nav1.7 and Nav1.8 in both the soma of capsaicin-sensitive small dorsal root ganglion (DRG) neurons and peripheral C-fibres and correspondingly enhanced sodium currents underlie the reduced conduction failure in diabetic high-firing frequency polymodal nociceptive C-fibres. This study sheds new light on the functional capability in the processing of pain signals occurring in the main axon of polymodal nociceptive C-fibres and reveals a novel mechanism that could underlie the hyperalgesia associated with diabetes.
Materials and methods

Animal models and behavioural tests
Male Sprague-Dawley rats weighing 200-250 g were fasted overnight to maximize the effectiveness of streptozotocin treatment. All experimental protocols were approved by an institutional animal use and protection committee. Diabetes mellitus was induced by a single subcutaneous injection of streptozotocin (Sigma, 70 mg/kg body weight). Age-matched rats in the control group received injections of saline. Glucose levels obtained from tail vein blood were measured 48 h after injection and the onset of diabetic conditions was defined as glucose levels 416.6 mM (300 mg/dl).
Mechanical sensitivity was tested with manual application of Von Frey hairs to the plantar surface of hindpaw. Each filament was applied 10 times and the paw withdrawal response frequency (the percentage of positive responses to the stimulus) was recorded. The force of a particular filament required to elicit 50% frequency of paw withdrawal was expressed as the mechanical threshold. Thermal sensitivity was tested by application of infrared heat to the plantar surface of hindpaw and the response latency was measured from an automated device readout, as described previously (Chen et al., 1999; Tappe et al., 2006) . coccygeal nerve. One is shown in Fig. 2A . The coccygeal nerve was carefully exposed and dissected from surrounding tissues at two sites. The proximal site (recording pool) was used for single C-fibre recording, and the distal site (drug pool) for drug administration to the nerve trunk. The receptive field of a single C-fibre was identified with both a mechanical stimulus using Von Frey hairs and an electrical stimulus using a pair of needle electrodes. In the drug pool, $5-6 cm of the nerve trunk was separated and covered with warm physiological saline with or without drug. Fine fascicles of the axons were teased from the nerve and the distal site was placed on a fine platinum recording electrode (30 mm in diameter) for single C-fibre recording. Action potentials were amplified (VC-11, Nihon Kohden) and recorded via a computer A/D board with a signal sampling rate of 10 or 100 kHz. Conduction velocities were determined by dividing the distance between the stimulating and recording electrodes by the action potential latency. Fibres with conduction velocities 52 m/s were classified as C-fibres. If the amplitude and shape of the action potentials remained the same during the recordings, they were defined as responses from a single C-fibre.
When C-fibre firings in the receptive field were induced by 100 g Von Frey hair as well as a small cotton ball with hot water (55-60 C), this fibre was identified as a polymodal nociceptor (Hu and Zhu, 1989) . After this test, a pair of needle electrodes was inserted into the receptive field to measure conduction velocity and conduction failure using various frequencies (2, 5 and 10 Hz) of electrical stimulus (0.8 ms in duration, Â 1.5 threshold intensity) for 60 s (Zhu et al., 2009) . The degree of conduction failure was calculated as the ratio of the number of failures/number of repetitive stimulus pulses Â 100. The conduction velocity of the first action potential was defined as the initial conduction velocity. The degree of conduction velocity slowing was determined by dividing the initial conduction velocity by the difference between the conduction velocity of the 50th action potential and initial conduction velocity. The other way is shown in Fig. 2B . The coccygeal nerve was carefully exposed at three sites. In addition to the recording and drug pools, a distal site (the stimulus pool) was used to electrically stimulate the nerve trunk. In the stimulus pool, the coccygeal nerve trunk was cut distally and its proximal end was placed on a pair of platinum stimulating electrodes and covered with warm ($37 C) mineral oil.
Intact dorsal root ganglion preparations and whole cell patch clamp recording
In anaesthetized rats, two L4 and L5 dorsal root ganglia were carefully removed and placed into artificial CSF. After removing the connective tissue, the ganglia were digested with a mixture of 0.4 mg/ml trypsin and 1.0 mg/ml type-A collagenase (Sigma) for 40 min at 37 C. The intact ganglia were then incubated in artificial CSF oxygenated with 95% O 2 and 5% CO 2 at 28 C for at least 1 h before transferring them to the recording chamber (Yang et al., 2009) . DRG neurons were visualized with a Â 40 water-immersion objective using a microscope (BX51WI; Olympus) equipped with infrared differential interference contrast optics. Whole-cell current and voltage recordings were acquired with an Axon200B ampliEer (Molecular Devices Corporation). Patch pipettes (4-7 M) were pulled from borosilicate glass capillaries on a vertical puller (model PP-83, Narishige). The series resistance was 10-20 M. Neurons were selected for further study if they had a resting membrane potential 5 À50 mV and if they exhibited overshooting action potentials. The artificial CSF contained (in mM): 124 NaCl, 2.5 KCl, 1.2 NaH 2 PO 4 , 1.0 MgCl 2 , 2.0 CaCl 2 , 25 NaHCO 3 and 10 glucose. The pipette solution contained (in mM): 140 KCl, 2 MgCl 2 , 10 HEPES, 2 Mg-ATP, pH 7.4. Osmolality was adjusted to 290-300 mOsm. The transient sodium current was recorded in a special bath solution containing (in mM): 65 NaCl, 30 tetraethylammonium-Cl, 45 choline-Cl, 0.1 CaCl 2 , 5 MgCl 2 , 0.1 CdCl 2 , 10 HEPES, 11 glucose, pH 7.4, 300 mOsm. The electrodes were filled with (in mM): 100 CsCl, 30 tetraethylammonium-Cl, 5 NaCl, 2 MgCl 2 , 0.1 CaCl 2 , 3 EGTA, 10 HEPES, 2 Mg-ATP, pH 7.4, 290-300 mOsm. For recording the persistent sodium current, an identical bath solution to the transient sodium current recording was used except for (in mM): 120 NaCl, 2 4-AP, 0.1 CdCl 2 , 1 CsCl. All chemicals were obtained from Sigma. Data were acquired with a Digidata 1322A acquisition system (Molecular Devices) using pCLAMP 9.0 software. Signals were low-pass filtered at 5 kHz, sampled at 10 kHz and analysed offline.
Immunofluorescence labelling
At 3-4 weeks after streptozotocin injection, rats were anaesthetized with pentobarbital sodium and transcardially perfused with saline followed by 4% paraformaldehyde. DRGs from thoracic and lumbar regions of the spinal column and coccygeal nerves were removed, post-fixed overnight in 4% paraformaldehyde and cryoprotected in 30% sucrose at 4 C until the tissue sank to the bottom of the container. Transverse DRG sections (14 mm) and sagittal coccygeal nerve sections (12 mm) were cut on a cryostat. To visualize sodium channels, double immunofluorescence labelling methods were used. Briefly, the sections were incubated with a solution containing 0.3% Triton X-100 and 1% bovine serum albumin for 3 h at room temperature. The sections then were incubated with anti-sodium channel antibodies and monoclonal anti-peripherin (1:1000, Sigma) antibody in phosphate buffered saline Tween for 24 h at 4 C. Antibodies for sodium channels used were anti-rabbit Nav1.7 (1:200, Alomone Labs), or anti-rabbit Nav1.8 (1:400, Alomone Labs). After three washes with phosphate buffered saline Tween, the sections were further incubated with the secondary antibodies Alexa Fluor 488 (goat anti-rabbit IgG) and Alexa Fluor 594 (goat anti-mouse IgG) (Molecular Probes) for 2 h at room temperature. All images were captured with an Olympus confocal microscope and processed with Adobe Photoshop software.
Western blotting
DRGs and coccygeal nerves were collected and homogenized in ice-cold lysis buffer containing (in mM): 50 Tris-HCl, pH 7.4, 150 NaCl, 5 EDTA, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulphate and standard protease inhibitors. Insoluble material was removed by centrifugation (13 000 rpm for 10 min) and the supernatant was collected. Protein concentration for each sample was determined by the bicinchoninic acid method using the MICRO BCA protein assay kit (Pierce). The membrane blots were blocked with 10% non-fat dry milk for 12 h and incubated with primary antibodies: anti-Nav1.7 (1:100), anti-Nav1.8 (1:100) overnight at 4 C. The membranes were then incubated with horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (1:10 000, Amersham Biosciences) for 2 h at room temperature. To normalize the loaded samples, mouse monoclonal anti-actin antibody (1:5000; GE Healthcare) was used, followed by incubation with horseradish peroxidase-conjugated goat anti-mouse IgG (1:5000; Pierce). Membranes were incubated with enhanced chemiluminescence reagents (Pierce), and images of the membrane were acquired with the CHEMIL-MAGER chemiluminescence imaging system and analysed with Image J software. The density of the band of interest (Nav 1.7 or Nav 1.8) was measured and normalized to the density of the b-actin band (Amersham Biosciences).
Statistical analysis
All results are presented as the mean AE SEM. An analysis of variance (ANOVA) for random measures was carried out, followed by either a post hoc Fisher's test or Dunnett's test to determine statistically significant differences for all data. P 5 0.05 was considered to be significant.
Results
Mechanical allodynia and thermal hyperalgesia in rats with early painful diabetic neuropathy
Following streptozotocin injection, most of the rats (480%) developed high levels of blood glucose (28.7 AE 0.7 mM, n = 28), which started on the third day after streptozotocin injection and remained so during the entire experimental period (Fig. 1A) . In contrast, vehicle-injected rats had normal blood glucose levels (7.49 AE 0.2 mM, Fig. 1A , n = 23). Sensitivity of diabetic rats with elevated blood glucose to mechanical and thermal stimuli was tested at different time points after streptozotocin injection. Compared to control rats (n = 11), diabetic rats showed a significant drop in response threshold to Von Frey hairs in bilateral hindpaws, reflecting mechanical allodynia (Fig. 1B , n = 25, P 5 0.001). This mechanical allodynia started on the third day after streptozotocin injection, persisting over the entire experimental period. In parallel, a dramatic thermal hyperalgesia to noxious plantar heat stimuli was found in diabetic rats (Fig. 1C , n = 11, P 5 0.001, n = 25). Therefore, it can be inferred that rats with early painful diabetic neuropathy develop strong mechanical allodynia and thermal hyperalgesia, which is consistent with a previous report (Hong et al., 2004) .
Reduced conduction failure in high-firing frequency polymodal nociceptive C-fibres in rats with early painful diabetic neuropathy
After 3-4 weeks following streptozotocin injection when stable high glucose level and significant hyperalgesia were produced, the sensitivity of polymodal nociceptive C-fibres to mechanical stimulation was tested. As shown in Fig. 2C , single polymodal nociceptive C-fibre in coccygeal nerves in diabetic rats (n = 27) showed hypersensitivity to sustained suprathreshold Von Frey hair stimulation (100 g for 60 s) when compared to control rats (n = 31). The mean firing frequency evoked by mechanical stimulation was significantly higher for the whole population of C-fibres in diabetic rats than that in control rats ( Fig. 2D , P 5 0.05). Furthermore, analysis of firing frequency of individual C-fibres revealed two clusters of C-fibre responses in diabetic rats, low-firing frequency (diabetic-low) (n = 17) and high-firing frequency Figure 1 Setup of diabetic animal model following subcutaneous injection of streptozotocin. (A) Average random blood glucose levels in control (n = 23) and diabetic rats (n = 28) for up to 21 days after injection of streptozotocin. The blood glucose of diabetic rats was significantly higher than that of control groups from the third day (*P 5 0.05). (B) Mechanical allodynia developed in diabetic (n = 25) but not control (n = 11) rats for both hindpaws. Note that paw withdrawal threshold decreased significantly from the third day following injection of streptozotocin (* †P 5 0.05). (C) Thermal hyperalgesia was observed by measuring paw withdrawal latency to radiant heat in control (n = 11) and diabetic rats (n = 25) for both sides. Note that paw withdrawal latencies significantly decreased in diabetic rats on the third day after injection of streptozotocin and remained at that level for up to 35 days of behavioural testing for both sides compared with control rats (* †P 5 0.05).
(Diabetic-hi) (n = 10) ( Supplementary Fig. 1 ). The high-firing frequency C-fibres account for about one-third of all C-fibres tested; these high-frequency fibres had a 3-fold higher response to mechanical stimulation than control rats ( Fig. 2D , P 5 0.05). This separation of C-fibres into low-and high-firing frequency subgroups in diabetic rats was based on the criteria reported by Chen and Levine (2001) . In a previous study of rats with vincristine-induced painful neuropathy (Tanner et al., 2003) , C-fibres were distributed into low-($50%) and high-firing frequency ($50%) fibres. Therefore, these changes in firing frequency may be a general characteristic of C-fibres that contribute to neuropathic pain. To further test whether the increased firing frequency of polymodal nociceptive C-fibres in diabetic rats was due to a change in conduction properties of C-fibres, the degree of conduction failure was quantitatively analysed by delivering repetitive electrical stimulation at different frequencies (2, 5 and 10 Hz) to the receptive field for 60 s. In control rats, conduction failures were observed along the main axon of a single C-fibre in a frequency-dependent manner and had an average failure rate of 13.13 AE 4.08% at 2 Hz, 39.47 AE 5.54% at 5 Hz and 64.25 AE 5.70% at 10 Hz ( Fig. 3A and E). In contrast, diabetic high-firing frequency C-fibres displayed a much lower failure rate compared to control rats; there were no failures at 2 Hz, 3.2 AE 2.0% at 5 Hz and 22.9 AE 7.4% at 10 Hz ( Fig. 3B and E; P 5 0.05, n = 31). Interestingly, we found that conduction failure was often accompanied by changes in conduction velocity. As shown in Fig. 3C , C-fibres in control rats exhibited a progressive slowing of conduction velocity in response to repetitive stimulation. The average slowing of conduction velocity for the 50th action potential compared to the first one was 15.57 AE 2.23% ( Fig. 3C and F, n = 8). In striking contrast, diabetic high-firing frequency C-fibres showed significantly less slowing of conduction velocity (9.48 AE 1.71%, Fig. 3D and F, P 5 0.05, n = 8). Analysis of the initial conduction velocity revealed that diabetic high-firing frequency C-fibres had significantly faster initial conduction velocities (0.88 AE 0.09 m/s, n = 7) than the controls (0.67 AE 0.02 m/s, showing that the mean number of mechanical stimulation-induced firing from all C-fibres in diabetic rats (Diabetic-all) was significantly higher than that in control rats (n = 27 versus 31, *P 5 0.05). Among all the diabetic C-fibres, approximately two-thirds of the fibres exhibit low-frequency firing (Diabetic-low), one-third exhibit high-frequency firing (Diabetic-hi). The firing frequency of diabetic-high C-fibres (n = 10) was much higher than that of controls (n = 31) and diabetic-low C-fibres (n = 17, *P 5 0.05). For the diabetic group, the C-fibres with 4200 spikes within 60 s were termed high-firing frequency C-fibres (Diabetic-hi). In contrast, diabetic-low was defined as the C-fibres with 5200 spikes within 60 s in response to the same stimulus. All data are represented as mean AE SEM. Diabetic-all = all C-fibres in the diabetic rats; Diabetic-hi = high-firing frequency C-fibres in the diabetic rats; Diabetic-low = low-firing frequency C-fibres in the diabetic rats. D = drug pool; E = electrical stimulation; M = mechanical Von-Frey stimulation; R = recording. (A) Original consecutive recordings of single C-fibre action potential firings from control rats in response to 5 Hz electrical stimulation (60 s, 1.5 Â threshold) of its peripheral receptive field. Inset shows a representative action potential. Every fifth sweep is shown (consecutive sweeps are at 1 s intervals) and they are displayed from top to bottom. Note that conduction failure occurred following repetitive stimulation. (B) Similar recordings of single C-fibre firings from diabetic rats in response to the same stimulation as in (A). Note that the degree of conduction failure was much lower in diabetic C-fibres than in controls. (C) Original consecutive recordings of single C-fibre action potential firing following 2 Hz electrical stimulation from control rats. Repetitive stimulation results in a progressive slowing of conduction velocity, shown as increased conduction latency. Every sixth sweep is shown (consecutive sweeps are at 3 s intervals) and they are displayed from top to bottom. (D) Similar recordings of single C-fibre firings from diabetic rats in response to the same stimulation as in (C). (E) Quantitative analysis showing that frequency-dependent conduction failure was strongly reduced in diabetic high-firing frequency (Diabetic-hi) C-fibres compared to control C-fibres (*P 5 0.05). (F) Quantitative analysis showing that Diabetic-hi C-fibres display less slowing of conduction velocity than control C-fibres (n = 8 versus 18, *P 5 0.05). (G) Initial conduction velocity of Diabetic-hi C-fibres (n = 7) was significantly greater than that of control C-fibres (n = 29, *P 5 0.05). All data are represented as mean AE SEM. Diabetic-hi = high-firing-frequency C-fibres in the diabetic rats.
recently demonstrated a marked increase in conduction velocity of C-fibres in rats with Taxol-induced painful neuropathy. When analysing the degree of slowing and the initial conduction velocity, we found a negative correlation (r = À 0.3, P 5 0.05). Taken together, these results suggest that the lower degree of conduction failure in diabetic high-firing frequency C-fibres might be associated with a faster initial conduction velocity and less slowing of conduction velocity.
Conduction failure occurs along the main axon of polymodal nociceptive C-fibres
To test whether conduction failure arises along the main axon of polymodal nociceptive C-fibres with uniform diameter and without arborization and which channels mediate conduction failure, we performed the following experiment with the paradigm shown in Fig. 2B . In control rats, repetitive electrical stimulation of the distal coccygeal nerve trunk produced conduction failure in single C-fibres that were isolated in the proximal site of the same nerve trunk (Fig. 4A) . Local administration of -dendrotoxin (-DTX, 0.5 nM), a selective blocker for low threshold, rapidly activating potassium currents (Kv1) (Hsiao et al., 2009) , on middle part of the coccygeal nerve trunk laying between the stimulating and recording electrodes significantly reversed the conduction failure of C-fibres (Fig. 4B-D , P 5 0.05, n = 6). This result suggests that conduction failure occurred along the main axon of C-fibres. In contrast to -DTX, low concentrations of tetrodotoxin (TTX; 5, 20, 100 nM) increased the conduction failure of polymodal nociceptive C-fibres in a dose-dependent manner ( Fig. 5A and E, P 5 0.05, n = 9). TTX under these low concentrations was reported to selectively block persistent sodium currents, with no obvious effect on transient sodium currents (Wu et al., 2005; Yang et al., 2009; Xie et al., 2011) . To determine whether a persistent sodium current was involved in the reduced conduction and 100 nM) enhanced the conduction failure in a dose-dependent manner in polymodal nociceptive C-fibres from control rats (n = 9, *P 5 0.05) and in diabetic high-firing frequency C-fibres (n = 20, *P 5 0.05). (F) Quantitative analysis showing that different concentrations of A-803467 increased the conduction failure in a dose-dependent manner on control C-fibres (n = 6, *P 5 0.05) and diabetic high-firing frequency C-fibres (n = 6, *P 5 0.05). All data are represented as mean AE SEM. Diabetic-hi = high-firing-frequency C-fibres in the diabetic rats. failure in diabetic high-firing frequency C-fibres, the same concentrations of TTX were tested and demonstrated to increase the conduction failure dramatically (Fig. 5B and E, P 5 0.05, n = 20). Normalization of the conduction failure to pre-TTX levels in each group revealed that TTX exhibited much stronger effects on conduction failure in diabetic high-firing frequency C-fibres than that of control C-fibres (P 5 0.05). To further determine the sodium channel subtypes that may be responsible for conduction failure of polymodal nociceptive C-fibres, we tested a selective Nav1.8 sodium channel blocker, A-803467 (Jarvis et al., 2007) and found that this blocker effectively increased the conduction failure in a dose-dependent manner (Fig. 5C and F, P 5 0.05, n = 6). Similar to TTX, the enhancing effect of A-803467 on conduction failure in diabetic rats was stronger than that in control rats ( Fig. 5D and F, P 5 0.05, n = 6).
Changes of membrane properties and excitability in small dorsal root ganglion neurons from rats with early painful diabetic neuropathy
To further explore the ionic mechanisms of conduction failure in polymodal nociceptive C-fibres, we analysed the membrane properties of small capsaicin-sensitive DRG neurons. A total of 216 small diameter (530 mm) DRG neurons were examined, 104 neurons from control rats and 112 from diabetic rats. Passive membrane properties including resting membrane potential and membrane capacitance were not significantly different between these two groups (Table 1) . However, the active membrane properties of small DRG neurons from diabetic rats represented significant differences compared with controls. Table 2 illustrates the augmented excitability of small diameter DRG neurons from diabetic rats. For example, the enhanced excitability is manifested as increased action potential amplitude, shorter action potential half-width, greater action potential slope, and lowered firing threshold (P 5 0.05, n = 22). More importantly, the mean firing frequency induced by a depolarizing current step was much higher in all small diameter DRG neurons tested from diabetic rats than that from control rats (Fig. 6A and B, P 5 0.05). Analysis of the firing frequency of individual neurons revealed two clusters of neurons in diabetic rats: low-firing frequency (approximately two-thirds of the neurons tested) and high-firing frequency (approximately one-third of the neurons tested) ( Supplementary  Fig. 2 ). Here we defined high-firing frequency neurons as those neurons that generated more than five spikes in response to a depolarizing current step (300 pA in intensity, 500 ms in duration), whereas low-firing frequency neurons exhibited less than five spikes. The discharges of diabetic high-firing frequency neurons were significantly higher than that of control neurons and diabetic low-firing frequency neurons (Fig. 6B, P 5 0.05) . Interestingly, the proportion of diabetic high-firing frequency neurons tested in vitro corresponds nicely to that of diabetic high-firing frequency C-fibres tested in vivo. Application of a low dose of TTX (100 nM) produced a significant inhibition of spikes evoked by the depolarizing current step (Fig. 6A ) in diabetic high-firing frequency neurons, suggesting an important role of persistent sodium current in the hyperexcitability of small DRG neurons in diabetic rats. Furthermore, to determine whether the after-hyperpolarization contributes to the enhanced excitability of diabetic DRG neurons, the properties of the after-hyperpolarization in high-firing frequency neurons were analysed. Figure 6C and D shows that both the peak amplitude and half-width of after-hyperpolarization were reduced in high-firing frequency neurons from diabetic rats when compared to control rats. The average amplitude of the after-hyperpolarization at the time points between 100 and 200 ms was decreased in diabetic rats ( Fig. 6D , P 5 0.05, n = 12). Additionally, to explore whether diabetic DRG neurons were prone to repetitive firing, paired current steps with an interval of 100 ms were applied to control and diabetic high-firing frequency neurons to ascertain the possible differences in the rheobase required to evoke the second spike. As depicted in Fig. 6E , the rheobase for the second spike was much lower in diabetic high-firing frequency neurons compared to control neurons ( Fig. 6E and F, n = 8 versus 13, P 5 0.05). These results indicate that early diabetes resulted in marked increases in high-firing frequency (Diabetic-hi) neuron and a control neuron in response to depolarizing pulses (increment, 50 pA). More than five spikes were considered as Diabetic-hi neurons. After the treatment with TTX (100 nM), the number of action potentials was reduced.
(B) The mean number of spikes evoked by the same stimulation as in (A) for the whole population of small diabetic neurons (n = 39) was significantly higher than control neurons (n = 18). Especially, the number of spikes for Diabetic-hi neurons (n = 12) was much greater than that for control (n = 18) and diabetic low-firing frequency (Diabetic-low) neurons (n = 27) (*P 5 0.05). (C) The traces were recorded with depolarizing pulses (5 ms, 50-150 pA) to elicit spikes from control DRG neurons and Diabetic-hi neurons. The measurement of some parameters for after-hyperpolarizations (AHP) is shown by the dotted line. The after-hyperpolarization amplitude was measured from the resting level to the nadir. The half-width of after-hyperpolarization was defined as the width of after-hyperpolarization at point midway between the resting level and peak of after-hyperpolarization. (D) Both the peak amplitude of after-hyperpolarization and average amplitude between 100 and 200 ms were lower in Diabetic-hi DRG neurons (n = 12) than in control neurons (n = 18, *P 5 0.05). Also, the half-width of after-hyperpolarization in Diabetic-hi DRG neurons (n = 12) was shorter than in control neurons (n = 18, *P 5 0.05).
(E) Representative recording traces in response to a paired current step in current-clamp mode for control and Diabetic-hi neurons. After the first spike elicited by a depolarizing current (700 pA, 1 ms) injection, with an interval of 100 ms, a second graded depolarizing current (duration, 1 ms; increment, 20 pA) was given to both two groups of DRG neurons to evoke a second spike. (F) The rheobase of the second action potential firing in the Diabetic-hi group (n = 8) was significantly lower than in the control group (n = 13, *P 5 0.05). All data are represented as mean AE SEM. Diabetic-hi = high-firing-frequency neurons in diabetic rats.
excitability and changes in the kinetics of after-hyperpolarization of small diameter DRG neurons.
Augmentation of sodium currents in small dorsal root ganglion neurons from rats with early painful diabetic neuropathy
The transient sodium current (I Na,T ) is a principal inward current that elicits the upstroke of the action potential. In small diameter DRG neurons, TTX can be used to separate total I Na,T into those currents that are sensitive (TTX-sensitive) and resistant (TTX-resistant) to blockage by this toxin (Roy and Narahashi, 1992; Elliott and Elliott, 1993) . Figure 7A shows original current traces and the I-V relations of total I Na,T in small DRG neurons from diabetic and control rats. The peak amplitude of I Na,T in the diabetic group was significantly increased compared to the control group ( Fig. 7A , P 5 0.05, n = 28). Figure 7B shows the isolated TTX-resistant and TTX-sensitive I Na,T . The average peak current densities for the total I Na,T , TTX-resistant and TTX-sensitive I Na,T were significantly enhanced in diabetic DRG neurons compared to control neurons ( Fig. 7B , P 5 0.01, n = 18 versus 16). To further determine which sodium channel subtypes may be responsible for the increased TTX-resistant I Na,T in the diabetic neurons, we isolated Nav1.8-mediated TTX-resistant sodium current (I Nav1.8 ) by bath application of A-803467 in the presence of TTX (Fig. 7C) . Analysis of peak current density revealed that the diabetic group displayed a much higher I Nav1.8 than the control group ( Fig. 7C , P 5 0.05, n = 13 versus 7). Persistent sodium current (I Na,P ) may influence the excitability and repetitive firing of DRG neurons, thus we determined whether this current was altered in small DRG neurons from diabetic animals. The total I Na,P was elicited by a voltage ramp from À 80 to 0 mV over a 3-s duration and is shown in Fig. 7D . Current density analysis revealed that diabetic rats had a larger I Na,P compared with controls ( Fig. 7D , P 5 0.05, n = 12 versus 18). Threshold voltage required to activate I Na,P was not significantly different between these two groups (P 4 0.05, n = 12, data not shown). TTX-sensitive and TTX-resistant components of I Na,P were further isolated and evaluated. It was found that the peak amplitude of both TTX-sensitive and TTX-resistant I Na,P was greater in diabetic groups in comparison with controls ( Fig. 7E , P 5 0.05, n = 9 versus 11).
Altered sodium channel expression in rats with early painful diabetic neuropathy
To test whether the increases in sodium currents in diabetic neurons could be due to altered sodium channel expression, we examined the expression level of different sodium channel subtypes in diabetic and control rats. After 3-4 weeks following streptozotocin injection, Nav1.7, a TTX-sensitive sodium channel subtype, displayed an upregulated expression in DRG neurons compared to the control group. Confocal analysis of double immunofluorescence experiments revealed Nav1.7 immunoreactivity in 42 AE 6% of peripherin-positive nociceptive DRG neurons in control rats, which was significantly increased to 92 AE 3% in diabetic rats (Fig. 8A and B, P 5 0.05, n = 4). In addition, diabetic rats showed much stronger Nav1.7 immunofluorescence intensity in peripherin-positive nociceptive neurons than control rats (Fig. 8A and B, P 5 0.05) . Similarly, we found a significant increase of Nav1.7 immunoreactivity in peripherin-positive nociceptive fibres of coccygeal nerves (Fig. 8C and D, P 5 0.05, n = 4) . In further support of enhanced Nav1.7 immunoreactivity observed in diabetic rats, we extracted crude homogenates of DRGs as well as coccygeal nerves and analysed Nav1.7 expression by western blot. Our quantitative results showed that the expression of Nav1.7 in both DRGs and coccygeal nerves was significantly increased in diabetic rats compared to control rats ( Fig. 8E and F , n = 4, P 5 0.05).
Similar to the increased expression pattern of Nav1.7, Nav1.8, a TTX-resistant sodium channel subtype, displayed an upregulated expression in diabetic rats. Confocal analysis of double immunofluorescence experiments demonstrated that Nav1.8 immunoreactivity was found in 48 AE 8% of peripherin-positive nociceptive DRG neurons in control rats, which was increased to 77 AE 6% in peripherin-positive nociceptive DRG neurons in diabetic rats ( Fig. 9A and B, P 5 0.05, n = 4). Nav1.8 immunofluorescence intensity was also much stronger in diabetic rats than control rats ( Fig. 9A and B, P 5 0.05, n = 4). In peripherin-positive nociceptive fibres of coccygeal nerves, the staining intensity of Nav1.8 immunofluorescence was increased dramatically in diabetic rats in comparison with control rats (Fig. 9C and D , P 5 0.05, n = 4). Consistent with the immunofluorescence staining, western blot analysis using anti-Nav1.8 antibody showed that expression level of Nav1.8 in both DRGs and coccygeal nerves was markedly enhanced in diabetic states compared to controls (Fig. 9E and F , P 5 0.05, n = 4).
Discussion
Frequency-dependent conduction failures occur along the main axon of polymodal nociceptive C-fibres One of the most striking findings of this study is that conduction failure was found to occur along the main axon of polymodal nociceptive C-fibres from DRG neurons; this failure may serve as a fine tuning mechanism for processing nociceptive information in the periphery. Recently, the function of the axon was recognized to be no longer limited to faithful conduction of action potentials but also involved in the complex operations of action potential (Bucher and Goaillard, 2011; Debanne et al., 2011) . Conduction failure has been observed in the terminals of axons with specialized structures such as branch points and varicosities, which is considered to be one of the crucial operations for information processing (Bielefeldt and Jackson, 1993; Weidner et al., 2003; Debanne, 2004) . However, whether conduction failure occurs along the main axon of the nerve trunk with uniform diameter Figure 7 Diabetic small DRG neurons exhibit larger total I Na,T and I Na,P than control neurons. (A) Top: representative traces of peak I Na,T obtained from a diabetic and control DRG neuron. Bottom: I-V curve of the total I Na,T showed a greater peak amplitude in diabetic (n = 28) compared with control DRG neurons (n = 25, *P 5 0.05). To record total transient sodium current in capsaicin-sensitive small DRG neurons (soma diameter 530 mm, cell capacitance 535 pF), we held cells at À 60 mV and then imposed voltage commands of depolarizing test pulse from À 80 to 20 mV in 300 ms preceded by a 700-ms prepulse held at À 120 mV (Huang and Song, 2008) . (B) Top: typical traces for the total I Na,T , TTX-sensitive (TTX-S) and TTX-resistant (TTX-R) I Na,T in a diabetic neuron. Bottom: the current density of the total I Na,T , TTX-resistant and TTX-sensitive I Na,T was greater in diabetic DRG neurons (n = 18) than in control neurons (n = 16, *P 5 0.05). TTX-resistant sodium current was recorded with a 700-ms prepulse to À 50 mV followed by a test pulse. TTX-sensitive sodium has not been established. In the present study, we utilized a preparation of polymodal nociceptive C-fibres from DRG neurons and tested the conduction properties along the main axon of this subset of C-fibres. In isolated single polymodal nociceptive C-fibres of the coocygeal nerve trunk in rats, failures occurred in a frequency-dependent manner following repetitive electrical stimulation of its receptive field (2-10 Hz). To exclude that failures might arise from within the receptive field, the same repetitive stimulation was applied to the distal site of the coccygeal nerve trunk; this did induce failures along the axon between the stimulating site and recording site. More importantly, conduction failures along the main axon can be reciprocally regulated by the administration of -DTX (0.5 nM) and TTX (5100 nM) or A-803467 into the middle region (conduction area) of nerves between stimulating and recording points. Thus, we infer that conduction failure does exist along the main axon of polymodal nociceptive C-fibres from DRG neurons, and this might contribute to the elaboration of nociceptive sensory processing in the periphery.
Conduction failure might serve as a self-inhibition mechanism for modulating adaptation in polymodal nociceptive C-fibres Following streptozotocin injection, most of the rats developed an elevated blood glucose level and long-lasting mechanical and thermal hyperalgesia. Analysis of conduction properties of polymodal nociceptive C-fibres revealed that the degree of conduction failure in diabetic high-firing frequency C-fibres was decreased by 3-fold compared to control C-fibres. In parallel, diabetic high-firing frequency C-fibres showed less slowing of conduction velocity than control C-fibres. These results suggest that conduction failure might serve as a regulator for the processing of pain signals under different conditions. For example, under normal physiological conditions, a greater degree of conduction failure along the main axon of polymodal nociceptive C-fibres could prevent transmission of excessive pain signals from the periphery to the CNS, thereby leading to a prominent adaptation to sustained noxious stimuli. Therefore, the conduction failure in response to repetitive activity is likely to serve as an intrinsic mechanism of self-inhibition in polymodal nociceptive C-fibres. However, under pathological conditions such as diabetes and inflammation, upregulated sodium channel expression enhances the excitability of small diameter DRG neurons and its unmyelinated axons (see below), which in turn leads to increased conduction velocity and a decrease in activity-dependent slowing of the conduction velocity, thus results in a lessening of conduction failure. This reduced conduction failure along the main axon of polymodal nociceptive C-fibres may not counteract the ongoing afferent barrage arising from the injured site, leading to an exaggerated inflow of pain signals to the CNS and thus resulting in pain hypersensitivity. In other words, polymodal nociceptive C-fibres enter a maladaptive state under pathological conditions owing to reduced self-inhibition by decreased conduction failure (Woolf and Ma, 2007) . In addition, firing patterns of C-fibres could also be modified by conduction failure based on the evidence that temporal patterns of firing can be modulated by previous activity in the C-fibres (Weidner et al., 2002; Debanne, 2004; Zhu et al., 2009) . Thus, changes in efficiency of signal conduction and encoding of firing patterns followed by activity-dependent conduction failure in polymodal nociceptive C-fibres, namely, conduction plasticity, might reveal a fundamental processing property of pain signalling.
Ionic mechanisms responsible for reduced conduction failure in diabetic states
Since the small size of C-fibres makes direct patch clamp recordings technically difficult, we analysed the membrane properties and ion currents in the cell bodies of small high-firing frequency DRG neurons to indirectly unravel the ionic mechanisms underlying reduced conduction failure in diabetic high-firing frequency C-fibres. Several lines of evidence suggest that this subgroup of high-firing frequency DRG neurons in vitro seen in diabetic rats is related with high-firing frequency diabetic C-fibres in vivo. First, both showed a hypersensitivity in diabetic states. Second, high-firing frequency DRG neurons in vitro were capsaicin-sensitive, indicative of the nociceptive nature of this subgroup of neurons, similarly the high-firing frequency C-fibres in vivo are polymodal nociceptors. Third, the proportion of high-firing frequency DRG neurons to all the diabetic neurons tested (approximately one-third) in vitro corresponds nicely to that of the high-firing frequency C-fibres (about one-third) to all the diabetic C-fibres tested in vivo. Based on the above evidence, we reasoned that ionic mechanisms underlying decreased conduction failure in high-firing frequency C-fibres in diabetic states can be revealed, in part, by the changes that occur in high-firing frequency diabetic DRG neurons. current was obtained by digital subtraction of the TTX-resistant current from the total current. (C) Top: current records were generated during voltage steps to 0 mV before and after the successive application of TTX (1 mM) and A-803467 (2 mM) in a diabetic neuron. Bottom: the current density of I Nav1.8 was greater in diabetic DRG neurons (n = 13) than in control neurons (n = 7, * P 5 0.05). (D) Left: representative I Na,P traces were obtained by a voltage ramp from À 80 to 0 mV over a 3-s duration. Right: the current density of I Na,P in diabetic DRG neurons (n = 12) was larger than in control neurons (n = 18, *P 5 0.05). (E) Left: representative traces for I Na,P in a diabetic neuron were obtained by digital subtraction of the currents after treatment with TTX (100 nM) from total currents. Top: total I Na,P ; Bottom: I Na,P after the application of TTX. Right: the peak TTX-sensitive and TTX-resistant I Na,P were both greater in diabetic DRG neurons (n = 9) than in control neurons (n = 11, *P 5 0.05). All data are represented as mean AE SEM.
Reduced conduction failure in diabetic C-fibres Brain 2012: 135; 359-375 | 371 Figure 8 Increased expression of Nav1.7 in DRGs and coccygeal nerves in diabetic rats compared to controls. (A) Double immunofluorescence staining of DRG neurons with C-fibre marker peripherin (red) and Nav1.7 antibody (green) in diabetic rats (right) and control rats (left). Top: Â20 magnification, Bottom: Â40 magnification. (B) Quantitative summary from double immunofluorescence experiments showing that in diabetic rats, Nav1.7 immunoreactivity in peripherin-positive nociceptive DRG neurons was increased in comparison with control rats. Both the percentage of Nav1.7-immunoreactive population and Nav1.7 immunofluorescence intensity are shown. (C) Double immunofluorescence staining of coccygeal nerves with peripherin (red) and Nav1.7 antibody (green) in diabetic rats (right) and control rats (left). (D) Quantitative analysis showing that Nav1.7 immunoreactivity in peripherin-positive nociceptive coccygeal nerves was enhanced in diabetic rats compared to control rats. (E) Expression of Nav1.7 shown by western blot analysis with DRGs and coccygeal nerves lysates derived from diabetic rats and control rats. (F) Quantitative summary from western blot analysis showing that Nav1.7 protein expression was significantly increased in diabetic rats compared to control rats. All data are represented as mean AE SEM. Scale bars: A = 100 mm (top) and 50 mm (bottom); C = 50 mm. *P 5 0.05. Figure 9 Increased expression of Nav1.8 in DRGs and coccygeal nerves in diabetic rats compared to controls. (A) Double immunofluorescence staining of DRG neurons with C-type fibre marker peripherin (red) and Nav1.8 antibody (green) in diabetic rats (right) and control rats (left). Top: Â 20 magnification, Bottom: Â 40 magnification. (B) Quantitative summary from double immunofluorescence experiments showing that in diabetic rats, Nav1.8 immunoreactivity in peripherin-positive nociceptive DRG neurons was increased in comparison with control rats. Both the percentage of Nav1.8-immunoreactive neurons and Nav1.8 immunofluorescence intensity are shown. (C) Double immunofluorescence staining of coccygeal nerves with peripherin (red) and Nav1.8 antibody (green) in diabetic rats (right) and control rats (left). (D) Quantitative analysis showing that Nav1.8 immunoreactivity in peripherin-positive nociceptive coccygeal nerves was enhanced in diabetic rats compared to control rats. (E) Expression of Nav1.8 shown by western blot analysis with DRGs and coccygeal nerves lysates derived from diabetic rats and control rats. (F) Quantitative summary from western blot analysis showing that Nav1.8 protein expression was significantly increased in diabetic rats compared to control rats. All data are represented as mean AE SEM. Scale bars: A = 100 mm (top) and 50 mm (bottom); C = 50 mm. *P 5 0.05.
In the present study, the peak amplitude and half-width of the after-hyperpolarization of high-firing frequency DRG neurons decreased in the diabetic state. The after-hyperpolarization plays an important role in eliciting the second spike and regulating spike frequency (Roper et al., 2003; Sculptoreanu and de Groat, 2003; Zhang et al., 2010) . Firing frequency of primary sensory neurons can be inhibited by the increased after-hyperpolarization (Hogan and Poroli, 2008) . Therefore, we infer that the lowered spike threshold and decreased after-hyperpolarization in small DRG neurons in diabetic states lead to the enhancement of excitability, speeding of conduction velocity, these in turn promote repetitive firing, thus resulting in the reduction of conduction failure.
Analysis of sodium currents showed that both TTX-sensitive and TTX-resistant I Na,T were significantly increased in small DRG neurons from diabetic rats. Importantly, with the use of a selective Nav1.8 sodium channel subtype blocker, A-803467, Nav1.8-mediated TTX-resistant I Na,T (I Nav1.8 ) was pharmacologically isolated and found to be profoundly enhanced in diabetic rats compared to control rats. This increased I Nav1.8 was strongly supported by upregulation of Nav1.8 expression in the cell body of small DRG neurons and its C-fibres. Consistent with our proposed causal link between excitability and conduction failure, administration of A-803467 produced a dose-dependent increase in conduction failure in the main axon of polymodal nociceptive C-fibres. In contrast to the well-studied I Na,T Bean, 2002, 2003) , the role of I Na,P in regulating the excitability of small DRG neurons in diabetic states has not been examined although augmentation of I Na,P was seen in DRG neurons after chronic compression of dorsal root ganglia (Hu and Xing, 1998; Maingret et al., 2008; Yang et al., 2009; Xie et al., 2011) . The present results revealed that TTX-sensitive and TTX-resistant I Na,P were much greater in diabetic rats than control rats. Among the TTX-sensitive sodium channels expressed in DRG, Nav1.7 is thought to be important in setting the threshold of action potential and ultimately regulating neuronal excitability (Dib-Hajj et al., 2005; Rush et al., 2006) . In diabetic rats, the expression of Nav1.7 is upregulated in DRG neurons, particularly in peripherin-positive small DRG neurons and C-fibres. Therefore, we infer that increased Nav1.7 expression may be implicated in the enhanced TTX-sensitive sodium current in small diabetic DRG neurons.
In addition, we found in the present study that administration of -DTX, a selective blocker for low threshold, rapidly activating potassium channel significantly reversed the conduction failure in polymodal nociceptive C-fibres. Similarly, our previous study (Zhu et al., 2009) reported that 4-AP (10-40 mM), a known fast potassium channel blocker (Sun et al., 2010; Shi and Sun, 2011) could dose-dependently reduce the conduction failure in C-fibres of rabbit saphenous nerve. Furthermore, our preliminary data showed that fast potassium current (I A ) was greatly reduced in diabetic small DRG neurons compared to control neurons (unpublished) . These results suggest a pivotal role of potassium channels in the occurrence of conduction failure and its plastic changes in diabetic rats. However, it should be pointed out that this study was not designed to address the role of potassium channel in the conduction failure, which remains to be further investigated in the future study.
In summary, our results revealed a novel hypothesis that pain, in a model of diabetic neuropathy in the rat, is mediated at least in part by a lessening of conduction failure along the main axon of polymodal nociceptive C-fibres. Therefore, targeting the receptors that are involved in the generation of conduction failure might represent a new potential therapeutic candidate for the treatment of chronic pain, including painful diabetic neuropathy.
